Decoy Therapeutics is trading at $1.64, down 11.59%, with no clear company-specific catalyst identified for the October 2 decline. - The latest reported company updates predate the session. - A reported consensus price-target revision to $3.06 appeared October 2, but available reporting does not link it to the intraday move. - Major indexes were higher, so the decline does not appear to track the broader market’s direction.